Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
7
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
fda
startups
national top stories
boston
investing
raleigh-durham blog main
san francisco blog main
alexion pharmaceuticals
alnylam pharmaceuticals
autoimmune disorders
drugs
glaxosmithkline
hepatitis b
medical device
new york blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
4d molecular therapeutics
abbvie
achaogen
acne
adams street partners
agenus
allosteric
amyotrophic lateral sclerosis (als)
antibiotics
astrazeneca
atlas venture
atopic dermatitis
auris health
avexis
What
disease
7
×
drug
medicines
therapeutics
adds
deal
hepatitis
infectious
new
pharma
pharmaceuticals
potential
year
address
ago
alliance
allosteric
alternative
approved
areas
autoimmune
bacteria
bio
biopharma
biosciences
bio’s
brii
building
business
candidate
caught
causing
clinic
companies
company
developer
dicerna
digital
earlier
elusive
Language
unset
Current search:
disease
×
deals
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed